Hyperbilirubinaemia is a common problem in daily practice for paediatricians and neonatologists. It a ects about 60% of all newborns. [1] Rebound hyperbilirubinaemia may occur after cessation of phototherapy, especially if the Coombs test is positive, if the infant was born prematurely, and if the duration of phototherapy was less than 72 hours. [2] Although the American Academy of Pediatrics has recommended that infants need not be kept in hospital for measurement of bilirubin levels in case of rebound after discontinuation of phototherapy, [1] we decided to perform a study to evaluate the optimal timing of measurement of bilirubin to assess potential rebound. We also evaluated haemoglobin (Hb) levels and duration of phototherapy for possible associations with a rebound in the bilirubin level.
Patients and methods
is prospective study was conducted at Mo d Children's Hospital, a tertiary paediatric referral hospital in Tehran, Iran. e hospital does not have an obstetric or postpartum ward, so all jaundiced newborns were referred from outside. All healthy term neonates (gestational age ≥37 weeks and birth weight >2 500 g) with indirect hyperbilirubinaemia ( ≥256.5 -290.7 µmol/l) who were admitted to the neonatology department during the 6 months October 2007 -March 2008 were included in the study. Exclusion criteria were neonatal infection, haemolysis, direct hyperbilirubinaemia (serum conjugated bilirubin >17.1 µmol/l if the total serum bilirubin (TSB) was <85.5 µmol/l, or >20% of TSB if the TSB was >85.5 µmol/l), glucose-6-phosphate dehydrogenase de ciency, a history of neonatal exchange transfusion, and parental refusal. Parents had to give signed consent before enrolment in the study. Phototherapy was delivered via a Philips TL 45/20W at a 15 -20 cm distance from the skin. A TSB level of ≥205.2 -222.3 µmol/l was considered the threshold for cessation of phototherapy, and all the infants were examined by a neonatologist. TSB was measured for each neonate at admission, on discontinuation of phototherapy, and 24 hours and 48 hours later. Student's t-test was used to compare the means, and the chi-square test was used to compare qualitative variables. SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) was used for analysis.
Results
Twenty-ve female and 37 male term neonates with indirect hyperbilirubinaemia were included. e mean admission age was 5.44 (standard deviation (SD)) 0.52 days for the girls and 7.19 (SD ±0.59) days for the boys (p=0.041). In 29 of the 62 cases (46.8%) the duration of phototherapy was less than 48 hours. ere were no signi cant di erences between girls and boys with regard to admission TSB (322.6 (SD ±9.4) µmol/l and 322.3 (SD ±7.3) µmol/l, respectively), Hb concentrations (15.0 (SD ±0.39) g/dl and 15.9 (SD ±0.36) g/dl, respectively), duration of phototherapy (46.7 (SD ±2.7) hours and 43.9 (SD ±2.4) hours, respectively), or TSB level before discontinuation of therapy (198.0 (SD ±4.6) µmol/l and 186.9 (SD ±4.6) µmol/l, respectively). TSB levels 24 hours after discontinuation of therapy were 186.0 (SD ±7.1) µmol/l and 205.7 (SD ±5.8) µmol/l in girls and boys, respectively (p=0.04). ere were no signi cant di erences between patients with a duration of phototherapy <48 hours and ≥48 hours with regard to bilirubin level at admission, before discharge, and 24 hours and 48 hours after discharge (p>0.05) ( Table 1 ). e mean TSB levels 24 and 48 hours later were 197.8 (SD ±4.6) and 195.1 (SD ±5.3) µmol/l, respectively, with no signi cant di erence between them (p>0.05). Of the patients, 4 had duration of phototherapy of ≥72 hours. ese 4 infants had a signi cantly lower bilirubin level 48 hours after termination of phototherapy (p=0.039), but otherwise there were no signi cant di erences between the patients with duration of phototherapy <72 hours and ≥72 hours. Only 1 of our patients was readmitted due to rebound hyperbilirubinaemia.
Discussion
A review of published studies suggests that signi cant rebound bilirubinaemia after discontinuation of phototherapy is rare, [3, 4] although some authors have reported it in 5.1 -13.2% of cases. [2, 5, 6] e variation in reported proportions of neonates who required further phototherapy may be due to di erent de nitions of rebound bilirubin level. Kaplan et al. [2] concluded that 'post-phototherapy neonatal bilirubin rebound to clinically signi cant levels may occur, especially in cases of prematurity, direct Coombs test positivity, and those treated ≥72 hours'.
[2] Maisels and Kring found that 14 of 303 term and near-term infants who received phototherapy were readmitted with rebound hyperbilirubinaemia. [7] ey concluded that it is unnecessary to keep infants in hospital to check rebound, but recommended follow-up measurement of the bilirubin level for infants who required phototherapy during hospitalisation and for those with haemolytic disease. [7] Some of the di erences between the studies may also be due to local di erences (e.g. hospitals with and without midwifery wards), funding policies of medical insurance organisations, and socioeconomic factors -many mothers and their babies are discharged less than 48 hours or even less than 24 hours after birth. In our study, all the neonates with hyperbilirubinaemia had been discharged. Only term neonates without a positive Coombs test were included, and only 1 patient was readmitted with rebound hyperbilirubinaemia (this was thought to be due to breastmilk jaundice). Our ndings are therefore similar to those of Del Vecchio et al., [8] who reported that 1 in 48 newborns required readmission for phototherapy.
A guideline from India (Symposium on AIIMS Protocols in Neonatology-II) recommends that discharge from hospital need not to be delayed to observe infants for rebounds. [9] However, the authors suggest that a repeat TSB measurement or clinical follow-up 24 hours after discharge is a useful option. [9] Our ndings concur with the American Academy of Pediatrics guideline, according to which infants without haemolytic disease do not require observation for rebound hyperbilirubinaemia and may be discharged from the hospital after discontinuation of phototherapy. [1] Yetman et al. also concluded that follow-up of infants discharged after termination of phototherapy solely for rebound hyperbilirubinaemia is unnecessary.
[10]
Conclusion
We did not nd signi cant di erences between TSB at the time of termination of phototherapy and 24 hours and 48 hours after cessation of phototherapy. We therefore do not recommend checking the TSB level for rebound bilirubinaemia. 
